Alterations on peripheral blood B-cell subpopulations in very early arthritis patients.

Moura, Rita A; Weinmann, Pamela; Pereira, Patrícia A; Caetano-Lopes, Joana; Canhão, Helena; Sousa, Elsa; Mourão, Ana F; Rodrigues, Ana M et al. · Rheumatology (Oxford) · 2010

case_control · Level III

Where this comes from

Abstract

To characterize circulating B-cell subpopulations of arthritis patients with <6 weeks of disease duration. Peripheral blood samples were collected from very early untreated polyarthritis patients, with <6 weeks of disease duration, for flow cytometric evaluation of B-cell subpopulations. Samples from patients who were later diagnosed as RA [very early RA (VERA)] were also collected 4-6 weeks after starting a low dose of prednisone (5-10 mg) and 4 months after reaching the minimum effective dose of MTX. A matched healthy group was used as a control. VERA patients have a lower percentage of total peripheral blood memory B cells (CD19(+)CD27(+)) and a significant decrease in the frequency of circulating pre-switch memory B cells (CD19(+)IgD(+)CD27(+)) as compared with controls. Therapy with corticosteroids or MTX was unable to restore the normal frequencies of these B-cell subpopulations. A significant decrease in peripheral pre-switch memory B cells is equally observed in other early arthritis patients. Furthermore, no significant differences are found in the frequencies of CD4(+) and CD8(+) T cells in all patient groups. In very early polyarthritis patients, there is a reduction in circulating pre-switch memory B cells. The reasons that may account for this effect are still unknown. Short-term corticosteroids and MTX do not seem to have a direct effect on circulating B-cell subpopulations in VERA patients.

Medical subject headings